WHO Clinical Staging of HIV/AIDS
The WHO clinical staging system for HIV/AIDS classifies patients into four progressive stages based on clinical conditions, from asymptomatic (Stage 1) to AIDS-defining conditions (Stage 4). It guides treatment decisions and prognosis assessment.
About
The WHO clinical staging system was developed for resource-limited settings where CD4 testing may not be available. Stage 1: Asymptomatic or persistent generalized lymphadenopathy. Stage 2: Moderate unexplained weight loss, recurrent respiratory infections, herpes zoster, angular cheilitis, recurrent oral ulcers, papular pruritic eruptions, fungal nail infections, seborrheic dermatitis. Stage 3: Severe unexplained weight loss, chronic unexplained diarrhea, persistent unexplained fever, oral candidiasis, oral hairy leukoplakia, pulmonary tuberculosis, severe bacterial infections, acute necrotizing ulcerative stomatitis/gingivitis/periodontitis. Stage 4: HIV wasting syndrome, Pneumocystis pneumonia, recurrent severe bacterial pneumonia, chronic herpes simplex, esophageal candidiasis, extrapulmonary tuberculosis, Kaposi sarcoma, cytomegalovirus, toxoplasmosis, cryptococcal meningitis, progressive multifocal leukoencephalopathy, lymphoma, HIV encephalopathy, disseminated mycosis.
Formula
The highest WHO clinical stage is determined by the most advanced HIV-related condition present.
Patients are classified into stages 1-4 based on the most advanced HIV-related clinical condition present. Stage 1: asymptomatic or mild symptoms. Stage 2: moderate symptoms. Stage 3: advanced symptoms. Stage 4: AIDS-defining conditions. ART is indicated for all patients regardless of stage, but stage 3-4 indicates urgent treatment initiation.
Score Interpretation
HIV/AIDS affected approximately 39 million people worldwide in 2023, with 1.3 million new infections and 630,000 deaths annually. WHO clinical staging remains essential in resource-limited settings for identifying patients who need urgent ART and OI prophylaxis. Early initiation of ART reduces mortality by 60-70%.
Stage 1 — 1–1
Asymptomatic or mild HIV disease.
Management: Initiate ART per guidelines. Monitor CD4 every 6 months.
Stage 2 — 2–2
Moderate HIV disease with mild symptoms.
Management: Initiate ART. OI prophylaxis based on CD4 count.
Stage 3 — 3–3
Advanced HIV disease.
Management: Urgent ART. Cotrimoxazole prophylaxis. TB screening and treatment.
Stage 4 (AIDS) — 4+
AIDS-defining conditions present.
Management: Urgent ART. Treat OIs aggressively. Hospitalization often required.
Reference Ranges
| Population | Normal Range |
|---|---|
| HIV-positive adults and adolescents | WHO Clinical Stages 1-4 |
Tabeeb+ Medical Review Team
Expert infectious disease review panel.
View medical review board & editorial policy →Example Calculation
Patient with HIV, CD4 200, presenting with oral candidiasis and pulmonary tuberculosis. Highest stage condition: pulmonary TB (Stage 3). WHO clinical stage: Stage 3.
Related Conditions
Related Medications
Common Mistakes
Using CD4 count alone to determine WHO stage without clinical assessment.
WHO staging is based on CLINICAL conditions, not CD4 count. Both are used together for comprehensive assessment.
Frequently Asked Questions
Do I need CD4 count if I use WHO staging?
References
- WHO. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. 2016.